Clik here to view.
Mitsubishi Electric, Kyoto Univ. and Tohoku Univ. Succeed in World’s First 3...
TOKYO Mitsubishi Electric Corporation (TOKYO:6503), Kyoto University and Tohoku University announced today the world’s first successful 3 tesla Magnetic Resonance Imaging (MRI) using a small model...
View ArticleClik here to view.
Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to...
BANNOCKBURN, Ill. & SAN FRANCISCO & TOKYO Baxalta Incorporated (NYSE: BXLT), Velocity Pharmaceutical Development, LLC (VPD) and Astellas Pharma Inc. (TSE:4503) today announced that...
View ArticleClik here to view.
注意-更正并替换： RayVio推出行业领先的水和环境净化处理用紫外LED灯
加州海沃德 (美国商业资讯)–先进的健康和卫生公司RayVio Corp.今日宣布，公司已推出新系列的紫外LED灯，能够通过一个小型表面贴装元器件(SMD)提供最高功率的输出。RayVio领先的技术通过成就强大的新一代便携式健康和卫生设备，实现了水和环境的紫外线消毒。...
View ArticleClik here to view.
Sumitomo Heavy Industries Announces Samsung Medical Center Starts Proton Therapy
TOKYO Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (“SHI”) today announces that Samsung Medical Center (“SMC”) in Seoul, Korea has commenced proton therapy*1 and the opening ceremony was held on May...
View ArticleClik here to view.
住友重機械： 韓国・サムスンメディカルセンターにおける陽子線治療の開始
東京 （ビジネスワイヤ） — 住友重機械工業株式会社（社長 別川俊介／以下、住友重機械）は、韓国サムスングループの基幹病院であるサムスンメディカルセンター（韓国・ソウル／以下、SMC）に納入した陽子線治療システム（以下、本システム）により、陽子線治療*1が開始され、本年５月３日にオープンニングセレモニーが開催されたことをご報告します。 このSmart News...
View ArticleClik here to view.
“Frontiers in Human Microbiota Symbiotic Interactions” 3rd Annual Meeting of...
HONG KONG The third “Bridging Biomedical Worlds” meeting, entitled “Frontiers in Human Microbiota Symbiotic Interactions” was dedicated to the vital role played by our host microbiota in human...
View ArticleClik here to view.
Dr. Reddy’s Enters the Branded Consumer Health Arena Through the Acquisition...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands...
View ArticleClik here to view.
Shenyang Research Institute Selects Provantis Preclinical Software Solution...
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the Shenyang Research Institute of Chemical Industry (SYRICI) has...
View ArticleClik here to view.
Acucela Announces Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
住友重机械工业宣布三星医疗中心启用质子治疗
东京 (美国商业资讯) — 住友重机械工业株式会社(TOKYO:6302) (“SHI”)今天宣布，韩国首尔三星医疗中心(“SMC”)已启用质子治疗*1，并于2016年5月3日举行了开业仪式。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleTaro Provides Results for Year Ended March 31, 2016
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2016. Quarter ended...
View ArticleClik here to view.
PerkinElmer Opens Customer Knowledge Center in Taiwan
TAIPEI, Taiwan PerkinElmer, Inc. held an opening ceremony for its new Taipei Customer Knowledge Center (CKC) located in Neihu District, Taipei City on May 27. President of PerkinElmer’s...
View ArticleClik here to view.
Masimo在2016年欧洲麻醉大会上展示下一代SedLine®脑功能监护仪
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天在英国伦敦召开的欧洲麻醉学会(ESA) 2016年欧洲麻醉大会上宣布，下一代SedLine®脑功能监护仪已获得CE标识并预定全面上市。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Takeda Provides Update on EU Marketing Authorization Application for NINLARO®...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
ハーキュリーズの新しいウェブサイトが22ndセンチュリーの禁煙技術を検討する独立の第2相／第3相臨床研究に脚光を当てる
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減でリードする植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE MKT:...
View ArticleClik here to view.
Samsung Bioepis Becomes First to Obtain European Commission Approval for...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Flixabi® – a biosimilar version of Remicade® (infliximab), also known as SB2 – for the treatment...
View ArticleClik here to view.
マシモが2016年欧州麻酔学会議で次世代SedLine®脳機能モニターを展示
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、英国ロンドンで開催中の欧州麻酔科学会（ESA）2016年欧州麻酔学会議（Euroanaesthesia Congress）にて、次世代SedLine®脳機能モニタリング技術のCEマーク取得と本格的な市場投入の計画を発表しました。 このSmart News...
View Article